Endocrine Testing Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report (2026-2035)

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Endocrine Testing Market Overview

Endocrine testing supports the evaluation of hormone levels and endocrine function, helping healthcare professionals assess hormonal imbalances and monitor conditions affecting glands such as the thyroid, pituitary, pancreas, and reproductive organs. These tests contribute to timely diagnosis, treatment planning, and ongoing patient management. The market is expanding due to the rising prevalence of endocrine disorders, increasing awareness of hormonal health, and growing adoption of advanced diagnostic testing. The market is poised to grow at a CAGR of 8.50% during the forecast period of 2026-2035. Demand for accurate and efficient testing is increasing across hospitals, clinics, and diagnostic laboratories.

Endocrine Testing Market Growth Analysis and Key Influencers

Endocrine Testing Market Dynamics

The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.

Endocrine Testing Market Growth Drivers

Expanding Specialized Diagnostic Services is Likely to Support the Market Expansion

The increasing need for specialized hormone testing is strengthening demand for endocrine diagnostics by enabling the detection and management of complex hormonal disorders. For instance, in January 2024, St Vincent’s Hospital Melbourne reported that its endocrine testing service had accepted more than 400 patient referrals in 2022 for complex blood tests covering rare endocrine conditions, including hormonal causes of hypertension, hypoglycemia, and cortisol abnormalities. Pfizer’s support expanded the service from two to four operating days per week, highlighting the growing need for specialized endocrine testing capacity and supporting market expansion.

Endocrine Testing Market Restraints

Limited Access to Specialized Testing Can Constrain Market Development

Limited access to specialized endocrine testing services can restrict market development, particularly where advanced diagnostic facilities and trained personnel are insufficient. Complex hormonal investigations often require specialized laboratory capabilities, experienced healthcare professionals, and appropriate testing infrastructure. These requirements can increase operational complexity and limit the availability of comprehensive endocrine testing in underserved healthcare systems. Consequently, disparities in diagnostic capacity may delay disease identification and reduce the adoption of advanced endocrine testing technologies.

Endocrine Testing Market Opportunities

Expanding Diagnostic Test Accessibility Creates New Growth Potential

Greater accessibility to essential and specialized diagnostic tests can create significant growth potential by supporting earlier detection and improved management of endocrine disorders. For instance, in October 2023, the World Health Organization expanded its Essential Diagnostics List to include parathyroid hormone testing for calcium homeostasis disorders and 17-hydroxyprogesterone testing for congenital adrenal hyperplasia. Such recommendations can encourage broader adoption of endocrine diagnostics and strengthen testing infrastructure, creating opportunities for continued market expansion.

Endocrine Testing Market Trends

Some of the notable trends in the market are the increasing adoption of automated, integrated, and multi-analyte endocrine testing platforms.

Increasing Adoption of Automated Hormone Testing Platforms Is Likely to Enhance Market Growth

The increasing adoption of automated hormone testing platforms is improving laboratory efficiency, supporting standardized workflows, and enabling multiple endocrine measurements through integrated systems. For instance, in May 2026, the FDA cleared an automated chemiluminescence immunoassay for total testosterone measurement, complementing previously cleared free testosterone and sex hormone-binding globulin assays. Such developments demonstrate the shift toward comprehensive and automated endocrine testing, which can streamline diagnostic workflows and support broader testing adoption, thereby enhancing market growth.

Endocrine Testing Market Share

Thyroid Testing Is Likely to Lead the Market by Type-Based Segmentation

The market is segmented into thyroid test, insulin test, prolactin test, human chorionic gonadotropin test, follicle-stimulating hormone test, luteinizing hormone test, and others. Among these, thyroid testing is expected to lead due to the substantial diagnostic need associated with thyroid disorders and their frequent occurrence across patient populations. According to Harkiranjit Kaur et al., 2025, thyroid disorders are among the most common endocrine problems during pregnancy, with hypothyroidism representing the predominant condition. This considerable testing requirement is expected to sustain demand for thyroid diagnostics and support the segment’s market position.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Endocrine Testing Market Analysis by Region

The regions included in the report are North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Among these regions, Asia Pacific is expected to lead the market, supported by its large and growing patient population, increasing awareness of endocrine disorders, expanding healthcare infrastructure, and improving access to diagnostic services. The region also presents substantial demand for thyroid, reproductive hormone, and metabolic testing due to the broad prevalence of endocrine-related conditions. Increasing investment in laboratory capabilities and diagnostic accessibility is expected to further strengthen the region’s position in the market.

Leading Players in the Endocrine Testing Market

Endocrine Testing Market Segmentation

Key Questions Answered in the Endocrine Testing Market Report

• What was the endocrine testing market value in 2025?
• What is the endocrine testing market forecast outlook for 2026-2035?
• What are the major factors aiding the endocrine testing market demand?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major endocrine testing market trends?
• Which type is expected to dominate the market segment?
• Which technology is anticipated to drive the market segment?
• Which end user is likely to dominate the market segment?
• Who are the key players involved in the endocrine testing market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

Research Methodology

This report is developed through a robust mixed-methods research design combining:

• Primary Research: In-depth interviews and consultations with endocrinologists, laboratory specialists, diagnostic testing professionals, hospital and clinic representatives, endocrine testing procurement managers, and industry experts across major markets, with emphasis on the test types, technologies, end-user settings, and regional dynamics covered in the report.
• Secondary Research: Peer-reviewed publications and clinical literature; regulatory and diagnostic information from the US FDA, EU EMA, India CDSCO, and Japan PMDA; epidemiological and healthcare data from the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), and other authoritative sources; company websites and product information; and data from patent, funding, investment, and clinical databases.
• Validation: Quantitative estimates are triangulated through top-down and bottom-up market modeling and validated through expert feedback, company-level analysis, historical market data, and cross-verification of regional and segment-level findings.